The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Parkinson's disease: a dual‐hit hypothesis
Open accessAbstract
Accumulating evidence suggests that sporadic Parkinson's disease has a long prodromal period during which several non-motor features develop, in particular, impairment of olfaction, vagal dysfunction and sleep disorder. Early sites of Lewy pathology are the olfactory bulb and enteric plexus of the stomach. We propose that a neurotropic pathogen, probably viral, enters the brain via two routes: (i) nasal, with anterograde progression into the temporal lobe; and (ii) gastric, secondary to swallowing of nasal secretions in saliva. These secretions might contain a neurotropic pathogen that, after penetration of the epithelial lining, could enter axons of the Meissner's plexus and, via transsynaptic transmission, reach the preganglionic parasympathetic motor neurones of the vagus nerve. This would allow retrograde transport into the medulla and, from here, into the pons and midbrain until the substantia nigra is reached and typical aspects of disease commence. Evidence for this theory from the perspective of olfactory and autonomic dysfunction is reviewed, and the possible routes of pathogenic invasion are considered. It is concluded that the most parsimonious explanation for the initial events of sporadic Parkinson's disease is pathogenic access to the brain through the stomach and nose - hence the term 'dual-hit'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The double-hit hypothesis proposed by Hawkes et al.135 supports their theory, pointing out that a-synuclein pathology is transmitted to the midbrain through two different routes, namely, from the nasal cavity to the temporal lobe or from the stomach, followed by nasal secretions in swallowed saliva.135”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [135]
Experimental — accuracy not yet measuredIn the citing paper
“Conversely, when the α-synuclein pathology firstly occurred in the olfactory bulbs, it spread further to the brain via the olfactory tract but it also went down to the ENS and it damaged its neurons [402].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [402]
In the citing paper
“Braak and colleagues hypothesized that alpha-synuclein pathology might start in either the OB and/or in the ENS possibly by an unknown pathogen and/or environmental toxin and then progresses towards the SN and further areas in the CNS.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Hawkes et al., 2007
In the citing paper
“The vagal nerve might provide a path for the spread of alpha-synuclein pathology from the ENS to the brain through the brainstem, midbrain, basal forebrain and finally the cortical areas (Braak et al., 2003;Hawkes et al., 2007)”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Hawkes et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Self-citationThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Self-citationHummel, T., Sekinger, B., Wolf, S. R., Pauli, E., & Kobal, G. (1997) · Chemical Senses · doi:10.1093/chemse/22.1.39 · Cited by 2,501
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Self-citationPaxinos, G., & Jürgen, K. (2004) · Cited by 1,478
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Self-citationSchenck, C. H., Bundlie, S. R., & Mahowald, M. W. (1996) · Neurology · doi:10.1212/wnl.46.2.388 · Cited by 1,083
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
Litvan, I., Bhatia, K. P., Burn, D. J., Goetz, C. G., Lang, A. E., McKeith, I. G., Quinn, N. P., Sethi, K. D., Shults, C. W., & Wenning, G. K. (2003) · Movement Disorders · doi:10.1002/mds.10459 · Cited by 1,011
Research works printed but not linked: 4
- Braak H, 2005, Parkinson's Disease: Progress in Research., 1
- Sulla M, 1996, Gastric emptying time and gastric motility in patients with untreated Parkinson's disease, Mov Disord, 11, 1041
- Schenck CH, 2003, REM behavior disorder (RBD), delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum & maximum tonic and/or phasic electromyographic abnormalities found during REM sleep, Sleep, 26, 316
- 10.1042/bse0410139 · DOI
Cited by
Sorted by citations
Items 401–500 of 1,000
Chaiwiang, N., & Poyomtip, T. (2019) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.66.2019.038 · Cited by 29
Yang, W., Hao, W., Meng, Z., Ding, S., Li, X., Zhang, T., Huang, W., Xu, L., Zhang, Y., Yang, J. M., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02128-5 · Cited by 29
van Vuuren, M. J., Nell, T. A., Carr, J. A., Kell, D. B., & Pretorius, E. (2020) · Biomolecules · doi:10.3390/biom11010030 · Cited by 33
Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson’s Disease
Dănău, A., Dumitrescu, L., Lefter, A., Tulbă, D., & Popescu, B. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111663 · Cited by 30
Olfactory function and Parkinson's disease in Southern Brazil
Santin, R., Fonseca, V. F., Bleil, C., Rieder, C. R. D. M., & Hilbig, A. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000200019 · Cited by 29
Deep Nasal Sinus Cavity Microbiota Dysbiosis in Parkinson’s Disease
Pal, G., Ramirez, V., Engen, P. A., Naqib, A., Forsyth, C. B., Green, S. J., Mahdavinia, M., Batra, P. S., Tajudeen, B. A., & Keshavarzian, A. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00254-y · Cited by 28
Samizadeh, M., Fallah, H., Toomarisahzabi, M., Rezaei, F., Rahimi-Danesh, M., Akhondzadeh, S., & Vaseghi, S. (2023) · Brain Sciences · doi:10.3390/brainsci13060914 · Cited by 33
Potential role of high‐field MRI for studies in Parkinson's disease
Schuff, N. W. (2009) · Movement Disorders · doi:10.1002/mds.22647 · Cited by 28
Parkinson's Disease and the Gut: Models of an Emerging Relationship
Bindas, A. J., Kulkarni, S., Koppes, R. A., & Koppes, A. N. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.071 · Cited by 27
Horsager, J., Walter, U., Fedorova, T. D., Andersen, K. B., Skjærbæk, C., Knudsen, K., Okkels, N., von Weitzel‐Mudersbach, P., Dyrskog, S., Bergholt, B., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.681413 · Cited by 28
Nielsen, S. D., Pearson, N. M., & Seidler, K. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147609 · Cited by 29
The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases
Tsafaras, G., & Baekelandt, V. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105806 · Cited by 28
Microbiota Dysbiosis in Parkinson Disease—In Search of a Biomarker
Nowak, J. M., Kopczyński, M. H., Friedman, A., Koziorowski, D., & Figura, M. (2022) · Biomedicines · doi:10.3390/biomedicines10092057 · Cited by 31
Nonmotor Subtyping in Parkinson's Disease
Sauerbier, A., Rosa‐Grilo, M., Qamar, M. A., & Chaudhuri, К. R. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.011 · Cited by 28
Tremblay, C., Mei, J., & Frasnelli, J. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102457 · Cited by 28
Sian‐Hülsmann, J., & Riederer, P. F. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-023-02723-5 · Cited by 30
Parkinson's disease: the nutrition perspective
Breasail, M. Ó., Smith, M. D., Tenison, E., Henderson, E. J., & Lithander, F. E. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003645 · Cited by 32
Predicting the onset of freezing of gait in Parkinson’s disease
Wang, F., Pan, Y., Zhang, M., & Hu, K. (2022) · BMC Neurology · doi:10.1186/s12883-022-02713-2 · Cited by 27
Considering REM Sleep Behavior Disorder in the Management of Parkinson’s Disease
Figorilli, M., Meloni, M., Lanza, G., Casaglia, E., Lecca, R., Saibene, F. L., Congiu, P., & Puligheddu, M. (2023) · Nature and Science of Sleep · doi:10.2147/nss.s266071 · Cited by 28
Olfactory Dysfunction in Parkinson’s Disease, Its Functional and Neuroanatomical Correlates
Torres-Pasillas, G., Chi-Castañeda, D., Castilla, P. C., Marín, G., Hernández‐Aguilar, M. E., Aranda-Abreu, G. E., Manzo, J. G., & García, L. I. (2023) · NeuroSci · doi:10.3390/neurosci4020013 · Cited by 27
Vojdani, A., Lerner, A., & Vojdani, E. (2021) · Cells · doi:10.3390/cells10051111 · Cited by 27
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Whittle, B. J., Izuogu, O. G., Lowes, H., Deen, D., Pyle, A., Coxhead, J., Lawson, R. A., Yarnall, A. J., Jackson, M. S., Santibanez‐Koref, M., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00636-y · Cited by 25
The Olfactory Trail of Neurodegenerative Diseases
Franco, R., Garrigós, C., & Lillo, J. (2024) · Cells · doi:10.3390/cells13070615 · Cited by 26
Buty and the beast: the complex role of butyrate in Parkinson’s disease
Elford, J. D., Becht, N. N., Garssen, J., Kraneveld, A. D., & Perez‐Pardo, P. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1388401 · Cited by 28
Progression of Nonmotor Symptoms in Parkinson’s Disease by Sex and Motor Laterality
Kurlawala, Z., Shadowen, P. H., McMillan, J. D., Beverly, L. J., & Friedland, R. P. (2021) · Parkinson s Disease · doi:10.1155/2021/8898887 · Cited by 26
Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease
Gros, P., Wang, X., Guan, J., Lang, A. E., Austin, P. C., Welk, B. K., Visanji, N. P., & Marras, C. (2021) · Movement Disorders · doi:10.1002/mds.28712 · Cited by 26
A Multi‐Step Model of Parkinson's Disease Pathogenesis
Heron, C. J. L., MacAskill, M. R., Mason, D. F., Dalrymple‐Alford, J. C., Anderson, T., Pitcher, T. L., & Myall, D. J. (2021) · Movement Disorders · doi:10.1002/mds.28719 · Cited by 26
Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
Lubomski, M., Xu, X., Holmes, A. J., Müller, S., Yang, J. Y. H., Davis, R. L., & Sue, C. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.881872 · Cited by 28
Leta, V., Boura, I., van Wamelen, D. J., Rodríguez‐Violante, M., Antonini, A., & Chaudhuri, К. R. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.004 · Cited by 26
Riegelman, E., Xue, K. S., Wang, J.-S., & Tang, L. (2024) · Nutrients · doi:10.3390/nu16132041 · Cited by 29
Unger, M. M., Möller, J. C., Mankel, K., Schmittinger, K., Eggert, K. M., Stamelou, M., Stiasny‐Kolster, K., Bohne, K., Bodden, M., Mayer, G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23933 · Cited by 26
Toward precision medicine in Parkinson's disease.
Bu, L.-L., Yang, K., Xiong, W.-X., Liu, F., Anderson, B., Wang, Y., & Wang, J. (2016) · PubMed Central · doi:10.3978/j.issn.2305-5839.2016.01.21 · Cited by 27
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Recasens, A., Carballo‐Carbajal, I., Parent, A., Bové, J., Gelpí, E., TOLOSA, E. S., & Vila, M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0509-1 · Cited by 27
Objective intestinal function in patients with idiopathic REM sleep behavior disorder
Knudsen, K., Fedorova, T. D., Hansen, A. K., Sommerauer, M., Haase, A., Svendsen, K. B., Otto, M., Østergaard, K., Krogh, K., & Borghammer, P. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.08.011 · Cited by 26
Huang, W., Xu, Y., Zhang, Y., Zhang, P., Zhang, Q., Zhang, Z., & Xu, F. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14774 · Cited by 26
Optimizing Parkinson’s disease diagnosis: the role of a dual nuclear imaging algorithm
Langston, J. W., Wiley, J. C., & Tagliati, M. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0041-9 · Cited by 25
Multisystem screening reveals SARS‐CoV ‐2 in neurons of the myenteric plexus and in megakaryocytes
Gray‐Rodriguez, S., Jensen, M. P., Otero‐Jimenez, M., Hanley, B. P., Swann, O. C., Ward, P. A., Salguero, F. J., Querido, N. R., Farkas, I., Velentza‐Almpani, E., et al. (2022) · The Journal of Pathology · doi:10.1002/path.5878 · Cited by 25
Patterns of Mixed Pathologies in Down Syndrome
Ichimata, S., Yoshida, K., Visanji, N. P., Lang, A. E., Nishida, N., & Kovacs, G. G. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215675 · Cited by 24
Javed, H., Fizur, N. M. M., Jha, N. K., Ashraf, G. M., & Ojha, S. K. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221223120251 · Cited by 25
Urinary tract infections trigger synucleinopathy via the innate immune response
Peelaerts, W., Mercado, G., George, S., Villumsen, M., Kasen, A., Aguileta, M., von Linstow, C. U., Sutter, A. B., Kuhn, E., Stetzik, L. A., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02562-4 · Cited by 25
Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology
Mou, L., Ding, W., & Fernández-Fúnez, P. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106210 · Cited by 28
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
Ultrasonography of the Vagus Nerve in the Diagnosis of Parkinson’s Disease
Laucius, O., Balnytė, R., Petrikonis, K., Matijošaitis, V., Jucevičiūtė, N., Vanagas, T., & Danielius, V. (2020) · Parkinson s Disease · doi:10.1155/2020/2627471 · Cited by 23
Proteomic Profile of Saliva in Parkinson’s Disease Patients: A Proof of Concept Study
Figura, M., Sitkiewicz, E., Świderska, B., Milanowski, Ł., Szlufik, S., Koziorowski, D., & Friedman, A. (2021) · Brain Sciences · doi:10.3390/brainsci11050661 · Cited by 24
Passive Immunization in Alpha-Synuclein Preclinical Animal Models
Folke, J., Ferreira, N., Brudek, T., Borghammer, P., & Berge, N. V. D. (2022) · Biomolecules · doi:10.3390/biom12020168 · Cited by 23
Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far
Boura, I., & Chaudhuri, К. R. (2022) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13461 · Cited by 26
Fu, S., Shih, L.-C., Wu, P.-H., Hsieh, Y., Lee, C., Lin, S., & Wang, H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.871710 · Cited by 27
Ahanger, I. A., & Dar, T. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102538 · Cited by 26
Алексеевна, Г. М., Davydova, T. V., Narkevich, V. B., Fomina, V. G., Wang, C., Кудрин, В. С., Morozova‐Roche, L. A., & Sewell, R. D. E. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.017 · Cited by 24
Heinemann, S. D., Posimo, J. M., Mason, D. M., Hutchison, D. F., & Leak, R. K. (2016) · Hippocampus · doi:10.1002/hipo.22580 · Cited by 24
Yoo, H. S., Chung, S. J., Lee, Y. H., Ye, B. S., Sohn, Y. H., & Lee, P. H. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09297-x · Cited by 24
Etiology and Pathogenesis of Parkinson’s Disease
Hatano, T., & Hattori, N. (2011) · InTech eBooks · doi:10.5772/20050 · Cited by 24
Parkinson's disease: Acquired frailty of archaic neural networks?
Diederich, N. J., & Parent, A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.10.003 · Cited by 25
Kurnik‐Łucka, M., Gil, K., Gajda, M., Thor, P. J., & Bugajski, A. J. (2015) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2015.0010 · Cited by 24
Tan, L. Y., Cunliffe, G., Hogan, M. P., Yeo, X. Y., Oh, C., Jin, B., Kang, J., Park, J., Kwon, M., Kim, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1380063 · Cited by 23
Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy
Guo, X., Song, D., Wu, M., Zhang, J., Li, J., & Yuan, L. (2025) · MedComm · doi:10.1002/mco2.70540 · Cited by 31
Vertebrate food products as a potential source of prion-like α-synuclein
Killinger, B. A., & Labrie, V. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0035-z · Cited by 23
Impact of Appendectomy on Gut Microbiota
Бабаханов, А. Т., ДЖУМАБЕКОВ, А. Т., Zhao, A., Kuandykov, Y., Tanabayeva, S. B., Fakhradiyev, I. R., Nazarenko, Y., & Saliev, T. M. (2021) · Surgical Infections · doi:10.1089/sur.2020.422 · Cited by 26
Sartucci, F., Bocci, T., Santin, M., Bongioanni, P., & Orlandi, G. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05183-5 · Cited by 23
The link between the gut microbiome, inflammation, and Parkinson’s disease
Nie, S., & Ge, Y. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12789-6 · Cited by 23
Li, H., Qian, J., Wang, Y., Wang, J., Mi, X., Qu, L., Song, N., & Xie, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102288 · Cited by 22
Bottoms up: the role of gut microbiota in brain health
Radisavljevic, N., Cirstea, M. S., & Finlay, B. B. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14506 · Cited by 24
Pmid, P., Kenney, C., Jankovic, J. J., & Tatter, S. B. (2009) · Cited by 23
Lu, H., Shen, Q., Xie, D., Zhao, Q., & Xu, Y. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01354-9 · Cited by 23
Neuroprotective approaches to halt Parkinson's disease progression
Sola, P., Krishnamurthy, P. T., Kumari, M., Byran, G., Gangadharappa, H. V., & Garikapati, K. K. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105380 · Cited by 21
Does gut brain axis has an impact on Parkinson’s disease (PD)?
Elangovan, A., Dahiya, B., Kirola, L., Iyer, M., Jeeth, P., Maharaj, S., Kumari, N., Lakhanpal, V., Michel, T. M., Rao, K. R. S. S., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102171 · Cited by 22
Park, S. J., Kim, K. W., & Lee, E. J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00994 · Cited by 27
Anorectal dysfunctions in Parkinson's disease
Kim, J., Sung, H. Y., Lee, K.-S., Kim, Y.-I., & Kim, H.-T. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.05.048 · Cited by 22
A future perspective on neurodegenerative diseases: nasopharyngeal and gut microbiota
Khan, F., & Oloketuyi, S. F. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13327 · Cited by 22
Imaging Parkinson’s disease below the neck
Borghammer, P., Knudsen, K., Fedorova, T. D., & Brooks, D. J. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0017-1 · Cited by 23
Imaging the Autonomic Nervous System in Parkinson’s Disease
Knudsen, K., & Borghammer, P. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0889-4 · Cited by 22
Structural Changes Observed in the Piriform Cortex in a Rat Model of Pre-motor Parkinson’s Disease
Sancandi, M., Schul, E. V., Economides, G., Constanti, A., & Mercer, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00479 · Cited by 22
Mason, D. M., Wang, Y., Bhatia, T. N., Miner, K. M., Trbojevic, S., Stolz, J. F., Luk, K. C., & Leak, R. K. (2019) · Brain Pathology · doi:10.1111/bpa.12718 · Cited by 22
Heimrich, K. G., Jacob, V. Y. P., Schaller, D., Stallmach, A., Witte, O. W., & Prell, T. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0087-3 · Cited by 22
Visual Dysfunction of the Superior Colliculus in De Novo Parkinsonian Patients
Moro, E., Bellot, E., Meoni, S., Pélissier, P., Hera, R., Michel Dojat, D., Coizet, V., & on behalf of the Superior Colliculus Study Group (2020) · Annals of Neurology · doi:10.1002/ana.25696 · Cited by 29
Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms
Blanco-Palmero, V. A., Azcárate-Díaz, F. J., Ruiz-Ortiz, M., Laespada-García, M. I., Suárez, P. R., Méndez-Guerrero, A., Aramendi-Ramos, M., Eguiburu-Jaime, J. L., Pérez‐Rivilla, A., Marchán-López, Á., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10444-6 · Cited by 21
The cross-sectional area of the vagus nerve is not reduced in Parkinson's disease patients
Sijben, L. C. J., Mess, W. H., Walter, U., Janssen, A. M. L., Kuijf, M. L., Oosterloo, M., Weber, W. E. J., & Janssen, M. L. F. (2022) · eNeurologicalSci · doi:10.1016/j.ensci.2022.100400 · Cited by 22
Haikal, C., Ortigosa-Pascual, L., Najarzadeh, Z., Bernfur, K., Svanbergsson, A., Otzen, D. E., Linse, S. S., & Li, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111594 · Cited by 21
Association between Parkinson’s disease and the faecal eukaryotic microbiota
Weis, S., Meisner, A., Schwiertz, A., Unger, M. M., Becker, A., Fassbender, K. C., Schnell, S., Schäfer, K., & Egert, M. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00244-0 · Cited by 21
Macdonald, J. A., Chen, J. L., Masuda‐Suzukake, M., Schweighauser, M., Jaunmuktane, Z., Warner, T. T., Holton, J. L., Grossman, A., Berks, R., Lavenir, I., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01291-7 · Cited by 22
Microbiome influences on neuro-immune interactions in neurodegenerative disease
Menees, K. B., Otero, B. A., & Tansey, M. G. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.07.006 · Cited by 24
Emery, D. C., Davies, M., Cerajewska, T. L., Taylor, J., Hazell, M., Paterson, A. R., Allen, S. J., & West, N. X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1026260 · Cited by 24
Nonlinear Weighting Ensemble Learning Model to Diagnose Parkinson’s Disease Using Multimodal Data
Castillo-Barnés, D., Martínez-Murcia, F. J., Jiménez-Mesa, C., Arco, J. E., Salas-Gonzalez, D., Ramı́rez, J., & Górriz, J. M. (2023) · International Journal of Neural Systems · doi:10.1142/s0129065723500417 · Cited by 21
Zhang, W., Dong, X., & Huang, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106787 · Cited by 22
Pavelka, L., Rawal, R., Ghosh, S., Pauly, C., Pauly, L., Hanff, A.-M. R., Kolber, P. L., Jónsdóttir, S. R., McIntyre, D., Azaiz, K., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1330321 · Cited by 22
Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
Licker, V., & Burkhard, P. R. (2014) · Translational Proteomics · doi:10.1016/j.trprot.2014.08.001 · Cited by 21
Nomura, T., Kishi, M., & Nakashima, K. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.3247 · Cited by 21
Gorecki, A. M., Bakeberg, M. C., Theunissen, F., Kenna, J. E., Hoes, M. E., Pfaff, A. L., Akkari, P. A., Dunlop, S. A., Kõks, S., Mastaglia, F. L., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.603849 · Cited by 21
Unilateral olfactory deficit in a hemiparkinson’s disease mouse model
Valle‐Leija, P., & Drucker-Colı́n, R. (2014) · Neuroreport · doi:10.1097/wnr.0000000000000218 · Cited by 21
Scheperjans, F. (2017) · Movement Disorders · doi:10.1002/mds.27197 · Cited by 22
Suo, X., Lei, D., Li, W., Li, L., Dai, J., Wang, S., Li, N., Cheng, L., Peng, R., Kemp, G. J., et al. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0725-5 · Cited by 20
Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses
Riederer, P. F., & ter Meulen, V. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02230-x · Cited by 21
Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach
Forero-Rodríguez, L. J., Josephs‐Spaulding, J., Flor, S., Pinzón, A. M., & Kaleta, C. (2021) · Antioxidants · doi:10.3390/antiox11010071 · Cited by 23
Similarities, differences and overlaps between frailty and Parkinson's disease
Ebina, J., Ebihara, S., & Kano, O. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14362 · Cited by 24
Nuclear imaging in Parkinson's disease: The past, the present, and the future
Golan, H., Volkov, O., & Shalom, E. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120220 · Cited by 21
Sharma, M., Sharma, N., & Khairnar, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03847-y · Cited by 20
Lázaro, D. F., & Lee, V. M. ‐. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.017 · Cited by 20
Yang, S., Kuan, W., & Spillantini, M. G. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13333 · Cited by 20
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease
Theis, H., Pavese, N., Rektorová, I., & van Eimeren, T. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230385 · Cited by 19
Parkinson’s disease: Are gut microbes involved?
Bhattarai, Y., & Kashyap, P. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00058.2020 · Cited by 21
Metadata
- Authors
- Hawkes, C. H., Del Tredici, K., & Braak, H.
- Affiliations
- Queen's Hospital (GB)
- Goethe University Frankfurt (DE)
- Corresponding author
- Hawkes, C. H.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2007-10-24
- Volume
- 33
- Issue
- 6
- Pages
- 599-614
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- PMC
- PMC7194308
- OpenAlex
- W2105047187
- Cited by
- 1,021
- References
- 163
- Citations by year
- 2026: 35 · 2025: 59 · 2024: 87 · 2023: 82 · 2022: 104 · 2021: 117 · 2020: 83 · 2019: 59 · 2018: 49 · 2017: 63 · 2016: 41 · 2015: 33 · 2014: 32 · 2013: 40 · 2012: 33
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neuropathology and Applied Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, neurotropic viruses, olfactory dysfunction, Lewy bodies, vagal dysfunction, sleep disorder, olfactory bulb, submucosal plexus, vagus nerve, substantia nigra, prodromal Parkinson's disease, viral pathogenesis
- MeSH terms
- Animals, Olfaction Disorders, Gastrointestinal Diseases, Heart Diseases, Humans, Models, Neurological, Parkinson Disease, Sleep Wake Disorders, Virus Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
